PATIENT AI Act Discussion Draft, AMA Issue Brief for Clinical AI Liability Released
Accountability and reimbursement for artificial intelligence (AI)-based technologies were highlighted topics of discussion last week.
TELCOR has identified ongoing processing challenges with BCBS New Jersey that laboratories should be aware of. When claims require medical records, BCBSNJ frequently does not take action on submitted documentation unless there is direct payer engagement. In our experience, speaking with a representative to match the claim to the medical records and maintaining consistent follow-up is often necessary before any processing occurs.
We also see BCBSNJ issue Denial Code 109 more frequently. While Blue Cross payers typically follow consistent jurisdiction rules configured within TELCOR RCM for efficient claim routing, BCBSNJ appears to apply jurisdiction requirements differently than other BCBS plans. As a result, a 109 denial often signals a jurisdiction mismatch rather than a true eligibility or coverage issue.
We recommend proactive follow-up and careful jurisdiction review when managing BCBSNJ claims to avoid unnecessary delays and denials.
- Sarah Stewart, Vice President, RCS
Accountability and reimbursement for artificial intelligence (AI)-based technologies were highlighted topics of discussion last week.
Lincoln, NE – November 2026 TELCOR is proud to announce the promotion of Stephanie Gonnerman to Senior Analyst, Revenue Cycle Management (RCM).
The Centers for Medicare and Medicaid Services (CMS) released a report on Oct. 20 detailing significant differences in the share of reported test...